rituximab
roche,biogen
['aza ', '+aza']
roccatello et al. aav with severe aki. rtx+cyc+methylpred+no maintenance vs cyc+aza maintenance. no difference in overall survival, 6-month therapeutic response rate, and 6-, and 12-month functional renal recovery. #acr22 abstr#1083 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC